 |
|||||||||||||||
|
|
|||||||||||||||
|
 |
|||
| Spring Meeting Trial Reports: 2011 / 2010 / 2009 | |||
| ID | Study Title | Status | |
| IND.183 | A Phase II Study of Sunitinib in Patients with Advanced Malignant Pleural Mesothelioma MORE... | Permanently Closed | |
| IND.190 | A Phase I-II Trial of MK-0646, a Monoclonal Antibody Against Insulin-Like Growth Factor-1 Receptor in Combination with Etoposide and Cisplatin in Extensive Stage Small Cell Lung Cancer MORE... | Closed | |
| IND.196 | A Phase I/II Study of Foretinib in Patients with Previously Treated Non-Small Cell Lung Cancer Receiving Standard Erlotinib Therapy MORE... | On Hold | |
| IND.207 | A Phase II Study of PF-03446962 in Patients with Advanced Malignant Pleural Mesothelioma MORE... | Open | |
| BR.10 | A Phase III Prospective Randomized Study of Adjuvant Chemotherapy with Vinorelbine and Cisplatin in Completely Resected Non-Small Cell Lung Cancer with Companion Tumour Marker Evaluation | Permanently Closed | |
|
BR.15 SWOG S0023 |
A Phase III Trial of Cisplatin/Etoposide/Radiotherapy with Consolidation Docetaxel Followed by Maintenance Therapy with ZD1839 or Placebo in Patients with Inoperable Locally Advanced Stage III Non-Small Cell Lung Cancer MORE... | Permanently Closed | |
|
BR.15C SWOG S9925 |
This Protocol is a Laboratory Companion for Southwest Oncology Group Coordinated Trials for Lung Cancer MORE... | Permanently Closed | |
|
BR.16 ECOG E5597 |
Phase III Chemoprevention Trial of Selenium Supplementation in Persons With Resected Stage 1 Non-Small Cell Lung Cancer MORE... | Closed | |
|
BR.17 EORTC 08983 |
Phase III Study of Tomudex and Cisplatin versus Cisplatin in Malignant Pleural Mesothelioma (EORTC: 08983) MORE... | Permanently Closed | |
| BR.18 | A Phase II/III Double Blind Randomized Trial of BMS-275291 versus Placebo in Patients Receiving Paclitaxel/Carboplatin Chemotherapy for the Treatment of Advanced or Metastatic Non-Small Cell Lung Cancer MORE... | Permanently Closed | |
| BR.19 | A Phase III Prospective Randomized Double Blind Placebo Controlled Trial of the Epidermal Growth Factor Receptor Antagonist ZD1839 (IRESSA) in Completely Resected Stage IB, II, and IIIA Non-Small Cell Lung Cancer MORE... | Permanently Closed | |
| BR.20 | A Phase II Study of ZD6474 or Placebo in Small Cell Lung Cancer Patients Who Have Complete or Partial Response to Induction Chemotherapy plus Radiation Therapy MORE... | Permanently Closed | |
| BR.21 | A Randomized Placebo Controlled Study of OSI-774 (Tarceva) in Patients with Incurable Stage IIIB/IV Non-Small Cell Lung Cancer Who Have Failed Standard Therapy for Advanced or Metastatic Disease MORE... | Permanently Closed | |
|
BR.22 SWOG S9920 |
A Randomized Phase III Trial of Surgery Alone or Surgery plus Preoperative Paclitaxel/Carboplatin in Clinical Stage IB (T2N0), II (T1-2N1, T3N0) and Selected IIIA (T3N1) Non-Small Cell Lung Cancer MORE... | Closed | |
|
BR.22C SWOG S9925 |
This Protocol is a Laboratory Companion for Southwest Oncology Group Coordinated Trials for Lung Cancer (SWOG: 9925) MORE... | Permanently Closed | |
|
BR.23 SWOG S0220 |
A Phase II Trial of Induction Chemoradiotherapy with Cisplatin/Etoposide Followed by Surgical Resection, Followed by Docetaxel, for Non-Small Cell Lung Cancer Involving the Superior Sulcus (Pancoast Tumours) MORE... | Closed | |
|
BR.23C SWOG S9925 |
This Protocol is a Laboratory Companion for Southwest Oncology Group Coordinated Trials for Lung Cancer MORE... | Permanently Closed | |
| BR.24 | A Phase II/III Double Blind Randomized Trial of AZD2171 versus Placebo in Patients Receiving Paclitaxel/Carboplatin Chemotherapy for the Treatment of Advanced or Metastatic Non-Small Cell Lung Cancer MORE... | Closed | |
| BR.25 | A Phase II Study of Hypofractionated 3-Dimensional Conformal Radiotherapy (3DCRT) for Inoperable Stage I/II Non-Small Cell Lung Cancer (NSCLC) MORE... | Closed | |
| BR.26 | A Double Blind Placebo Controlled Randomized Trial of PF-804 in Patients With Incurable Stage IIIB/IV Non-small Cell Lung Cancer After Failure of Standard Therapy for Advanced or Metastatic Disease MORE... | Open | |
|
BR.28 MLG CONVERT |
Concurrent ONce-daily VErsus twice-daily RadioTherapy: A 2-Arm Randomized Controlled Trial of Concurrent Chemo-Radiotherapy Comparing Twice-daily and Once-daily Radiotherapy Schedules in Patients with Limited Stage Small Cell Lung Cancer (SCLC) and Good Performance Status MORE... | Open | |
| BR.29 | A Double Blind Randomized Trial of Cediranib versus Placebo in Patients Receiving Paclitaxel/Carboplatin Chemotherapy for the Treatment of Advanced or Metastatic Non-Small Cell Lung Cancer ) MORE... | Closed | |
|
BRC.1 RTOG 0214 |
A Phase III Comparison of Prophylactic Cranial Irradiation versus Observation in Patients with Locally Advanced Non-Small Cell Lung Cancer MORE... | Closed | |
|
BRC.2 ECOG E1505 |
A Phase III Randomized Trial of Adjuvant Chemotherapy with or without Bevacizumab For Patients with Completely Resected Stage IB (> 4 CM) - IIIA Non-Small Cell Lung Cancer (NSCLC) MORE... | Open | |
| BRC.2E |
A Prospective Economic Analysis of NCIC CTG BRC.2/E1505 A Phase III Randomized Trial of Adjuvant Chemotherapy with or without Bevacizumab For Patients with Completely Resected Stage IB (> 4 CM) - IIIA Non-Small Cell Lung Cancer (NSCLC) MORE... |
Open | |
|
BRC.3 SWOG S0124 |
A Randomized Phase III Trial of Cisplatin and Irinotecan (NSC-616348) versus Cisplatin and Etoposide in Patients with Extensive Stage Small Cell Lung Cancer (E-SCLC) MORE... | Permanently Closed | |
|
BRC.4 NCCTG N0723 |
A Phase III Biomarker Validation Study of Second-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Randomized to Pemetrexed Versus Erlotinib MORE... | Permanently Closed | |
|
BRC.5 CALGB 140503 |
A Phase III Randomized Trial of Lobectomy versus Sublobar Resection for Small (< 2cm) Peripheral Non-Small Cell Lung Cancer MORE... | Open | |
| If you have any questions, comments or suggestions, please contact our |